S&P 500 7,722.60 ▲ 45.83 (+0.60%) DOW 52,377.57 ▲ 15.97 (+0.03%) NASDAQ 26,477.81 ▲ 308.43 (+1.18%) US Markets Closed â€ĸ 04:54 AM ET

IVA

Inventiva S.A.

Price Chart
Latest Quote

$3.69

+0.02 (+0.68%)
Current Price
Previous Close $3.66
Open $3.77
Day High $3.85
Day Low $3.62
Volume 1,782,494
Fetched: 2026-10-28T06:50:33
Stock Information
Note: Financial values converted from EUR to USD
Shares Outstanding 236.22M
Total Debt $154.40M
Cash Equivalents $184.81M
Revenue $2.73M
Net Income $-275.58M
Sector Healthcare
Industry Biotechnology
Market Cap $870.47M
EPS (TTM) $-0.62
Exchange NGM
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$843.35M
Sales$2.73M
Income$-275.58M
Book/sh$0.28
Cash/sh$0.70
Employees87
Financial Ratios
Quick Ratio2.73
Current Ratio3.81
Debt/Eq235.23
Returns & Margins
ROA-42.69%
ROE-989.05%
Gross Margin78.26%
Operating Margin-5337.32%
Ownership
Institutional Ownership36.97%
Insider & Institutional transactions data not available
Valuation Ratios
Forward P/E-4.95
P/S354.43
P/B13.12
Analyst Data
Recommendationstrong_buy
Target Price$15.20
Technical Indicators
SMA20$3.34
SMA50$3.88
SMA200$4.91
RSI59.14
ATR0.2517
Shares Float162.98M
Short Float3.74%
Short Ratio4.20
Volatility1.00
Rel Volume0.53
Performance History
Week+13.04%
Month+4.39%
Quarter-18.29%
6 Months-26.45%
YTD-22.58%
Year-40.56%
3 Years-2.77%
5 Years-73.68%
10 Years-72.54%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-10-27 $3.68 1,782,500
2026-10-26 $3.66 3,332,200
2026-10-23 $3.71 4,712,700
2026-10-22 $3.60 2,397,100
2026-10-21 $3.55 5,242,500
2026-10-20 $3.26 2,636,400
2026-10-19 $2.98 3,952,700
2026-10-16 $2.94 4,854,200
2026-10-15 $3.11 2,906,200
2026-10-14 $2.87 3,150,600
2026-10-13 $2.87 2,507,900
2026-10-12 $3.12 3,264,800
2026-10-09 $3.16 2,788,800
2026-10-08 $3.32 2,173,200
2026-10-07 $3.37 2,403,600
2026-10-06 $3.46 2,200,300
2026-10-05 $3.48 1,697,500
2026-10-02 $3.56 4,885,900
2026-10-01 $3.46 5,324,900
2026-09-30 $3.69 4,801,000
2026-09-29 $3.29 3,832,600
2026-09-28 $3.53 3,484,300
About Inventiva S.A.

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. The company also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. Inventiva S.A. was incorporated in 2011 and is headquartered in Daix, France.

📰 Latest News
No news articles available at the moment. Check back later for updates on IVA.
Period:
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Total Revenue $5,037,079 $10,334,831 $19,637,079 $13,684,270
Operating Revenue $5,037,079 $10,334,831 $19,637,079 $13,684,270
Expenses
Interest Expense $37,712,359 $13,683,146 $5,817,977 $794,382
Total Expenses $154,343,819 $115,940,449 $134,991,011 $77,568,539
Other Income Expense $-214,103,370 $-88,587,640 $-3,280,899 $3,288,764
Net Non Operating Interest Income Expense $-34,469,663 $-12,437,079 $-4,756,180 $-408,989
Total Other Finance Cost $66,292 $38,202 $51,685 $52,809
Interest Expense Non Operating $37,712,359 $13,683,146 $5,817,977 $794,382
Operating Expense $154,343,819 $115,940,449 $134,991,011 $77,568,539
Other Operating Expenses $-4,294,382 $-6,164,045 $-6,388,764 $-7,785,393
Selling And Marketing Expense $5,439,326 $1,894,382 $1,971,910 $2,657,303
General And Administrative Expense $55,113,483 $17,317,977 $15,564,045 $14,506,742
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-397,907,863 $-206,979,774 $-124,074,157 $-60,982,022
Net Interest Income $-34,469,663 $-12,437,079 $-4,756,180 $-408,989
Interest Income $3,308,989 $1,284,270 $1,113,483 $438,202
Normalized Income $-237,625,280 $-140,802,808 $-123,311,516 $-64,268,813
Net Income From Continuing And Discontinued Operation $-397,907,863 $-206,979,774 $-124,074,157 $-60,982,022
Total Operating Income As Reported $-158,441,572 $-109,615,730 $-115,403,370 $-64,168,539
Net Income Common Stockholders $-397,907,863 $-206,979,774 $-124,074,157 $-60,982,022
Net Income $-397,907,863 $-206,979,774 $-124,074,157 $-60,982,022
Net Income Including Noncontrolling Interests $-397,904,492 $-206,982,021 $-124,073,033 $-60,982,022
Net Income Continuous Operations $-397,904,492 $-206,982,021 $-124,073,033 $-60,982,022
Pretax Income $-397,879,773 $-206,630,336 $-123,391,011 $-61,004,494
Special Income Charges $-9,133,708 $-4,010,112 $-49,438 $-146,067
Earnings From Equity Interest $-393,258 $-351,685 $-2,264,045 $0
Interest Income Non Operating $3,308,989 $1,284,270 $1,113,483 $438,202
Operating Income $-149,306,741 $-105,605,617 $-115,353,932 $-63,884,269
Depreciation Amortization Depletion Income Statement $284,270 $779,775 $234,831 $247,191
Depreciation And Amortization In Income Statement $284,270 $779,775 $234,831 $247,191
Per Share
Diluted EPS $-2.13 $-3.46 $-2.73 $-1.47
Basic EPS $-2.13 $-3.46 $-2.73 $-1.47
Other
Tax Effect Of Unusual Items $-53,427,528 $-22,058,989 $-254,213 $1,973
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-142,835,954 $-98,870,786 $-113,635,954 $-61,591,011
Total Unusual Items $-213,710,111 $-88,235,955 $-1,016,854 $3,288,764
Total Unusual Items Excluding Goodwill $-213,710,111 $-88,235,955 $-1,016,854 $3,288,764
Reconciled Depreciation $3,621,348 $5,840,449 $2,920,225 $1,907,865
EBITDA (Bullshit earnings) $-356,546,066 $-187,106,741 $-114,652,808 $-58,302,247
EBIT $-360,167,414 $-192,947,190 $-117,573,033 $-60,210,112
Diluted Average Shares $209,425,191 $67,167,079 $50,957,077 $46,572,732
Basic Average Shares $209,425,191 $67,167,079 $50,957,077 $46,572,732
Diluted NI Availto Com Stockholders $-397,907,863 $-206,979,774 $-124,074,157 $-60,982,022
Tax Provision $24,719 $351,685 $682,022 $-22,472
Gain On Sale Of Ppe $320,225 $168,539 $0 $-10,112
Restructuring And Mergern Acquisition $9,453,933 $4,178,652 $49,438 $135,955
Gain On Sale Of Security $-204,576,403 $-84,225,842 $-967,416 $3,434,831
Research And Development $97,801,123 $102,112,359 $123,608,988 $67,942,696
Selling General And Administration $60,552,809 $19,212,359 $17,535,955 $17,164,045
Other Gand A $12,222,472 $10,531,461 $9,983,146 $9,806,742
Insurance And Claims $1,740,449 $0 $0 -
Salaries And Wages $41,150,562 $6,786,517 $5,580,899 $4,700,000
Write Off - $417,978 $0 $0
Impairment Of Capital Assets - $2,007,865 $0 $0
Other Taxes - - $0 $0
Provision For Doubtful Accounts - - $0 $0
Fetched: 2026-10-20
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $-32,252,809 $-119,880,898 $-36,598,876 $50,458,427
Total Assets $280,349,437 $133,670,786 $78,158,427 $130,341,572
Total Non Current Assets $5,667,416 $8,377,528 $24,015,730 $10,811,236
Non Current Prepaid Assets $1,305,618 $1,176,404 $11,297,753 $1,801,124
Non Current Deferred Assets $214,607 $243,820 $252,809 $0
Non Current Deferred Taxes Assets $214,607 $243,820 $252,809 $0
Goodwill And Other Intangible Assets $205,618 $53,933 $608,989 $638,202
Other Intangible Assets $205,618 $53,933 $608,989 $638,202
Current Assets $274,684,268 $125,293,258 $54,144,944 $119,532,584
Other Current Assets $591,011 $392,135 $473,034 $316,854
Prepaid Assets $4,440,449 $2,743,820 $5,231,461 $9,664,045
Inventory $0 $0 $468,539 $419,101
Receivables $10,248,315 $13,659,550 $17,648,315 $10,497,753
Other Receivables $1,883,146 $1,831,461 $1,665,169 $313,483
Taxes Receivable $6,100,000 $11,231,461 $11,705,618 $10,184,270
Accounts Receivable $2,265,169 $596,629 $4,277,528 $0
Cash Cash Equivalents And Short Term Investments $259,404,493 $108,497,752 $30,323,595 $98,634,831
Cash And Cash Equivalents $111,586,516 $108,497,752 $30,244,944 $97,457,303
Cash Equivalents $92,840,449 $79,387,640 $20,149,438 $18,874,157
Cash Financial $18,746,067 $29,110,112 $10,095,506 $78,583,146
Investmentin Financial Assets - - $10,112,360 $786,517
Non Current Accounts Receivable - - - $73,034
Hedging Assets Current - - - $0
Other Non Current Assets - - - -
Debt
Total Debt $67,257,303 $61,043,820 $42,122,472 $38,780,899
Long Term Debt And Capital Lease Obligation $30,956,180 $54,450,562 $36,158,427 $32,206,741
Long Term Debt $30,130,337 $52,051,685 $31,364,045 $28,574,157
Current Debt And Capital Lease Obligation $36,301,123 $6,593,258 $5,964,045 $6,574,157
Current Debt $34,013,483 $3,761,798 $3,382,022 $5,139,326
Other Current Borrowings $34,013,483 $3,761,798 $3,382,022 $5,139,326
Net Debt - - $4,501,124 -
Liabilities
Total Liabilities Net Minority Interest $312,396,628 $253,497,752 $114,148,314 $79,244,943
Total Non Current Liabilities Net Minority Interest $225,455,055 $117,844,943 $57,791,011 $44,749,438
Other Non Current Liabilities $59,368,539 $33,974,157 $8,268,539 $-2,247
Derivative Product Liabilities $134,140,449 $27,320,225 $11,533,708 $11,096,629
Non Current Deferred Liabilities $141,573 $120,225 $78,652 $61,798
Current Liabilities $86,941,573 $135,652,808 $56,357,303 $34,495,505
Other Current Liabilities $1,124 $82,473,033 - $-1,124
Current Deferred Liabilities $0 $0 $6,742 $6,742
Payables And Accrued Expenses $49,435,955 $46,586,517 $50,386,517 $27,915,730
Payables $37,369,663 $44,630,337 $48,656,180 $26,410,112
Other Payable $6,148,315 $3,297,753 $2,125,843 $2,110,112
Total Tax Payable $1,988,764 $4,408,989 $4,194,382 $2,548,315
Accounts Payable $29,232,584 $36,923,595 $42,335,955 $21,751,685
Current Deferred Taxes Liabilities - - $0 $0
Equity
Common Stock Equity $-32,047,191 $-119,826,966 $-35,989,887 $51,096,629
Total Equity Gross Minority Interest $-32,047,191 $-119,826,966 $-35,989,887 $51,096,629
Stockholders Equity $-32,047,191 $-119,826,966 $-35,989,887 $51,096,629
Gains Losses Not Affecting Retained Earnings $-229,826,965 $-193,877,527 $-139,312,359 $-83,771,910
Other Equity Adjustments $-230,541,572 $-194,551,684 $-139,982,022 $-83,467,415
Retained Earnings $-397,907,863 $-206,979,774 $-124,074,157 $-60,982,022
Long Term Equity Investment $592,135 $1,279,775 $1,601,124 $0
Other
Treasury Shares Number $66,911 $135,418 $119,230 -
Ordinary Shares Number $217,053,288 $107,485,832 $58,557,086 $47,341,763
Share Issued $217,120,199 $107,621,250 $58,676,317 $47,341,763
Tangible Book Value $-32,252,809 $-119,880,898 $-36,598,876 $50,458,427
Invested Capital $32,096,629 $-64,013,483 $-1,243,820 $84,810,112
Working Capital $187,742,696 $-10,359,551 $-2,212,360 $85,037,078
Capital Lease Obligations $3,113,483 $5,230,337 $7,376,404 $5,067,416
Total Capitalization $-1,916,854 $-67,775,281 $-4,625,843 $79,670,786
Foreign Currency Translation Adjustments $714,607 $674,157 $669,663 $-304,494
Additional Paid In Capital $593,516,851 $279,955,055 $226,811,235 $195,377,527
Capital Stock $2,170,787 $1,075,281 $585,393 $473,034
Common Stock $2,170,787 $1,075,281 $585,393 $473,034
Employee Benefits $848,315 $1,979,775 $1,751,685 $1,386,517
Non Current Pension And Other Postretirement Benefit Plans $848,315 $1,979,775 $1,751,685 $1,386,517
Non Current Deferred Revenue $141,573 $120,225 $78,652 $61,798
Long Term Capital Lease Obligation $825,843 $2,398,876 $4,794,382 $3,632,584
Current Deferred Revenue $0 $0 $6,742 $6,742
Current Capital Lease Obligation $2,287,640 $2,831,461 $2,582,022 $1,434,831
Current Provisions $1,203,371 - - -
Current Accrued Expenses $12,066,292 $1,956,180 $1,730,337 $1,505,618
Investments And Advances $592,135 $1,279,775 $1,601,124 $0
Net PPE $3,349,438 $5,623,595 $10,255,056 $8,298,876
Accumulated Depreciation $-19,056,180 $-17,070,786 $-12,037,079 $-9,613,483
Gross PPE $22,405,618 $22,694,382 $22,292,135 $17,912,359
Construction In Progress $0 $22,472 $129,213 $73,034
Other Properties $12,947,191 $12,041,573 $11,774,157 $7,615,730
Machinery Furniture Equipment $5,367,416 $6,538,202 $6,296,629 $6,131,461
Buildings And Improvements $3,897,753 $3,898,876 $3,898,876 $3,898,876
Land And Improvements $193,258 $193,258 $193,258 $193,258
Properties $0 $0 $0 $0
Other Short Term Investments $147,817,977 $0 $78,652 $1,177,528
Available For Sale Securities - - $10,112,360 $786,517
Other Inventories - - $468,539 $419,101
Fetched: 2026-10-20
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $-118,124,719 $-96,922,471 $-92,307,865 $-51,111,236
Operating Activities
Operating Cash Flow $-117,847,190 $-96,548,314 $-91,701,123 $-50,480,899
Cash Flow From Continuing Operating Activities $-117,849,438 $-96,547,191 $-91,701,123 $-50,479,775
Operating Gains Losses $1,950,562 $-582,022 $2,597,753 $385,393
Investing Activities
Capital Expenditure $-277,528 $-374,157 $-606,742 $-630,337
Investing Cash Flow $-149,647,190 $9,825,843 $-8,686,517 $9,964,045
Cash Flow From Continuing Investing Activities $-149,646,067 $9,825,843 $-8,686,517 $9,962,921
Net Other Investing Changes $-1,124 - - $1,124
Financing Activities
Issuance Of Capital Stock $231,956,179 $64,424,719 $34,369,663 $9,917,977
Financing Cash Flow $271,107,864 $163,586,516 $32,675,281 $41,874,157
Cash Flow From Continuing Financing Activities $271,106,740 $163,586,516 $32,675,281 $41,874,157
Net Other Financing Charges $-19,250,562 $11,343,820 $2,908,989 $33,942,696
Cash Dividends Paid $0 $0 $0 -
Net Common Stock Issuance $231,956,179 $64,424,719 $34,369,663 $9,917,977
Common Stock Issuance $231,956,179 $64,424,719 $34,369,663 $9,917,977
Other
Repayment Of Debt $-6,719,101 $-5,608,989 $-4,603,371 $-1,986,517
Issuance Of Debt $0 $27,995,505 $0 $33,942,696
End Cash Position $111,586,516 $108,498,876 $30,244,944 $97,456,179
Beginning Cash Position $108,498,876 $30,244,944 $97,456,179 $97,250,561
Effect Of Exchange Rate Changes $-525,843 $1,389,888 $500,000 $-1,151,685
Changes In Cash $3,613,483 $76,864,045 $-67,711,236 $1,357,303
Interest Paid Cff $-278,652 $0 $0 -
Proceeds From Stock Option Exercised $65,400,000 $65,431,460 $0 $0
Net Issuance Payments Of Debt $-6,719,101 $22,386,517 $-4,603,371 $31,956,180
Net Long Term Debt Issuance $-6,719,101 $22,386,517 $-4,603,371 $31,956,180
Long Term Debt Payments $-6,719,101 $-5,608,989 $-4,603,371 $-1,986,517
Long Term Debt Issuance $0 $27,995,505 $0 $33,942,696
Net Investment Purchase And Sale $-149,368,539 $10,200,000 $-8,226,966 $10,547,191
Purchase Of Investment $-149,368,539 - $-9,325,843 $-1,124
Net PPE Purchase And Sale $-277,528 $-374,157 $-459,551 $-584,270
Sale Of PPE $0 $0 $147,191 $46,067
Purchase Of PPE $-277,528 $-374,157 $-606,742 $-630,337
Taxes Refund Paid $5,522,472 $5,992,135 $5,865,169 $3,992,135
Change In Working Capital $1,984,270 $1,886,517 $19,446,067 $6,419,101
Change In Other Working Capital $-1,842,697 $2,015,730 $3,584,270 $-1,893,258
Change In Payables And Accrued Expense $2,871,910 $-3,750,562 $22,474,157 $3,971,910
Change In Payable $2,871,910 $-3,750,562 $22,474,157 $3,971,910
Change In Inventory $0 $468,539 $-49,438 $21,348
Change In Receivables $955,056 $3,152,809 $-6,562,921 $4,319,101
Other Non Cash Items $239,486,516 $98,665,168 $2,411,236 $1,215,730
Stock Based Compensation $30,077,528 $4,022,472 $4,459,551 $2,492,135
Deferred Tax $-2,582,022 $-5,393,258 $-5,326,966 $-5,911,236
Deferred Income Tax $-2,582,022 $-5,393,258 $-5,326,966 $-5,911,236
Depreciation Amortization Depletion $3,621,348 $5,840,449 $2,920,225 $1,907,865
Depreciation And Amortization $3,621,348 $5,840,449 $2,920,225 $1,907,865
Depreciation $3,621,348 $5,840,449 $2,920,225 $1,907,865
Earnings Losses From Equity Investments $393,258 $170,787 $2,264,045 $0
Net Foreign Currency Exchange Gain Loss $1,530,337 $-1,265,169 $333,708 $385,393
Gain Loss On Sale Of PPE $26,966 $512,360 $0 $0
Net Income From Continuing Operations $-397,907,863 $-206,979,774 $-124,074,157 $-60,982,022
Sale Of Investment - $10,200,000 $1,098,876 $10,548,315
Fetched: 2026-10-20